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Astaxanthin (ATX) is a powerful antioxidant that occurs naturally in a wide variety of living organisms. Previous
studies have shown that ATX has effects of eliminating oxygen free radicals and can protect organs from ischemia/
reperfusion (IR) induced injury. The present study was designed to further investigate the protective effects of ATX
on oxidative stress induced toxicity in tubular epithelial cells and on IR induced renal injury in mice. ATX, at a
concentration of 250 nM, attenuated 100 μM H2O2-inudced viability decrease of tubular epithelial cells. In vivo, ATX
preserved renal function 12 h or 24 h post IR. Pretreatment of ATX via oral gavage for 14 consecutive days prior to
IR dramatically prevented IR induced histological damage 24 h post IR. Histological results showed that the
pathohistological score, number of apoptotic cells, and the expression of α-smooth muscle actin were significantly
decreased by pretreatment of ATX. In addition, oxidative stress and inflammation in kidney samples were significantly
reduced by ATX 24 h post IR. Taken together, the current study suggests that pretreatment of ATX is effective in
preserving renal function and histology via antioxidant activity.
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Kidney transplantation presents one of the gold standard
therapies for end-stage renal diseases. Given the storage
of organs from decreased donors available for trans-
plantation, transplants using so-called “marginal” organs
have increased despite their reduced viability and in-
creased immunogenicity compared with living donor
renal allografts [1,2]. Ischemia/reperfusion (IR), an inev-
itable consequence of kidney transplantation, is one of
the major contributors to the development of primary
injury, and delayed graft function in kidney transplant-
ation, leading to worse long-term function [3,4].
Although the mechanisms by which organ damage oc-
curs in IR-induced renal injury are incompletely under-
stood, it has been suggested that oxidative injury
following IR most likely contributed to the pathogenesis
of IR [5]. During the ischemia phase, ischemia-induced* Correspondence: xiaopinggu1@gmail.com; dr.guohongqian@gmail.com
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unless otherwise stated.hypoxia could induce ATP depletion and hypoxanthine
accumulation. After reintroduction of blood flow, react-
ive oxygen species (ROS) are generated [6], leading to
tubular apoptosis/necrosis and local inflammation [7].
As a result of oxidative and inflammatory injury caused
by IR, tubular epithelial cells might undergo profound
functional alterations including losing tight junctions
and epithelial-to-mesenchymal transition (EMT) [8,9].
Previous reports have demonstrated that deficiency of
antioxidant could exacerbate IR injury and antioxidants
such as superoxide dismutase, catalase, or vitamin E had
beneficial effects for IR injury [10,11], supporting oxida-
tive stress as a major contributor in the development of
IR-induced injury.
Astaxanthin (ATX) is a carotenoid pigment naturally
existing in seafood, such as salmon, shells of crabs and
shrimps, as well as a wide variety of plants and algae
[12]. The United States FDA approved ATX as a feed
additive for the aquaculture industry in 1987 and ap-
proved its use as a dietary supplement in 1999 [13]. The
molecular structure of ATX is similar to that of β-
carotene (Additional file 1: Figure S1), which gives ATX
antioxidant capacity [14]. ATX exhibits free radicalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and oxidative damage to cell membranes, cells, and tis-
sues, suggesting ATX as a powerful biological antioxidant
[15]. Unlike carotenoids, ATX has oxygenated groups on
each ring structure (Additional file 1: Figure S1), making
ATX highly polar and dramatically enhancing its mem-
brane function to protect against degenerative conditions.
This makes ATX a significantly greater antioxidant than
β-carotene [16]. Previous studies on animal models have
shown protective effects of ATX in IR-induced liver [17],
brain [18,19], or cardiovascular [20] injury by reducing
oxidant-induced damage. However, the protective effect of
ATX against IR-induced renal injury still remains unknown.
The present study was therefore designed to examine
the therapeutic effect of ATX in IR-induced renal injury
using an IR model in mice. We hypothesize that pre-
treatment of ATX could offer protective effects against
IR-induced renal injury by reducing ROS, tubular apop-
tosis, inflammation, and EMT. To the best of our know-
ledge, this is the first study designed to explore the
feasibility of using ATX, a powerful antioxidant, for IR-
induced renal injury.
Materials and methods
Cells culture and treatment
Human tubular epithelial cells (HTECs) were obtained
from Dr. Hao Chen (National Clinical Research Center
of Kidney Diseases, Nanjing University, Nanjing, China)
and cultured in Roswell Park Memorial Institute 1604
medium (RPMI 1640, Life Science, Shanghai, China)
supplemented with 10% fetal bovine serum (FBS, Life
Science). Culture incubator was set at 37°C with 5%
CO2. In order to produce oxidative stress, H2O2 was
freshly prepared prior to each experiment. Free type of
ATX (≥97%, Sigma-Aldrich, St. Louis, MO, USA) was
dissolved in 0.5% DMSO. The cells were pretreated with
ATX at concentration of 250 nM for 24 h followed by
exposure to 100 μM of H2O2 in the presence of the
same concentrations of ATX for another 2 h.
Cell viability assay
Cell viability was evaluated by the Cell Counting Kit-8
(CCK-8, Life Science) test. Five thousand cells were seeded
into a 96-well culture plate and cultured in the serum-free
growth medium. According to the instructions provided
by the manufacturer, 100 μl of CCK-8 solution were added
to each well and the cells were incubated for a further 2 h.
After indicated time points, absorbance was measured at
450 nm with a multidetection micro-plate reader (Versamax,
Downingtown, PA, USA).
Animals and treatment
All experimental protocols conducted on animals were
performed in accordance with the standards establishedby the Institution Animal Care and Use Committee at
Nanjing University. Male ICR mice weighing 20-25 g
were housed in stainless steel cages and given free access
to food and water. Mice were randomly divided into four
groups: The sham group received olive oil via oral gav-
age for 14 consecutive days [17] before the sham surgery
(n = 6); the sham + ATX group received 5 mg/kg/day
ATX (3,3-dihydroxy beta, β-carotene-4,4-dione, Sigma-
Aldrich) dissolved in olive oil before the sham surgery
(n = 6); the IR group received olive oil before the induc-
tion of renal IR (n = 16); the IR + ATX group received
ATX before the induction of renal IR (n = 16). Mice in
IR groups were sacrificed 12 h or 24 h post IR while
mice in sham groups were sacrificed 24 h post sham sur-
gery. Blood samples were collected for measurement of
renal function while kidneys were collected for molecu-
lar analysis.
Mice model of renal IR injury
Mice were anesthetized intraperitoneally with a mixture
of ketamine (100 mg/kg) and midazolam (5 mg/kg).
After anesthetization, mice were subjected to renal IR
injury as previously described [21]. Briefly, after abdom-
inal laparotomy, right kidney were exposed and re-
moved. Left renal pedicle was exposed and clamped with
vascular clamp for 45 min to induce ischemia. After
clamp, vascular clamp was removed to induce reperfusion
and the incision was closed in 2 layers. Sham-operated
control animals underwent right kidney removal without
occlusion of left renal artery.
Measurement of renal function
Serum were separated by centrifuging blood samples
and stored at −80°C until analysis of blood serum urea
nitrogen (BUN) and urine creatinine (Cr). The concen-
trations of BUN and Cr were assessed in duplicated with
a commercially available assay kit (BioAssay System,
Hayward, CA, USA) according to the instructions.
Histological analysis
Middle part of kidney were fixed in 4% formaldehyde,
dehydrated, and paraffin embedded. Tissue sections
(5 μm) were stained with hematoxylin and eosin (HE).
Kidney sections were examined in a blinded manner and
scored to evaluate the degree of injury. The score
reflected the grading of tubular necrosis, cast formation,
tubular dilation, and loss of brush border in 10 ran-
domly selected, non-overlapping fields (200X) as follow-
ing: 0, none; 1, ≤10%; 2, 11 to 25%; 3, 26 to 45%; 4, 46 to
75%; and 5, ≥76% [22,23].
Immunofluorescent analysis
After dewaxing and rehydration, the tissue sections were
incubated with 3% BSA/0.3% Triton X-100 for 30 min at
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tions were incubated at room temperature with rabbit
anti-myeloperoxidase (MPO, 1:100, Santa Cruz Biotech-
nologies, Santa Cruz, CA, USA), mouse anti-α smooth
muscle actin (α-SMA) (1:100, Boster, Wuhan, China)
overnight. Control tissue sections were similarly pre-
pared except no primary antibody was added. After rinse
with PBS, the sections were incubated with Alexa-594-
conjugated secondary antibody (Life Science). After
rinses with PBS, the slides were incubated with 4′,6-dia-
midino-2-phenylindole (DAPI, Life Science). The fluor-
escent was detected by confocal in darkness.
Detection of apoptosis
Quantitative determination of apoptosis in kidney sec-
tions was assessed by a terminal transferase-mediated
dUTP nick-end labeling (TUNEL) assay using an In Situ
Cell Death Detection Kit (Roche, Basel, Switzerland).
After dewaxing and rehydration, the tissue sections were
permeabilized with 0.1% Triton X-100 for 10 min. Incu-
bation with label solution was used to detect the apop-
totic cells according to the instructions. Apoptotic score
was achieved by counting the number of positive nuclei
in 10 random fields.
Measurement of superoxide dismutase (SOD) and
malondialdehyde (MDA)
Renal SOD and MDA levels were determined under the
guidance of the kit instructions (Jiancheng Bioengineer-
ing Institute, Nanjing, China). Briefly, renal tissues were
homogenized. After centrifugation, SOD was determined
using the xanthine oxidase method while MDA was deter-
mined by the thiobarbituric acid (TBA) reaction. Each
assay was repeated three times. Protein concentration was
determined by the BCA Protein assay (Pierce, Rockford,
IL) using bovine serum albumin (BSA) as a standard.
Determination of myeloperoxidase (MPO) activity
Commercial available kit (Jiancheng Bioengineering In-
stitute) was used to detect MPO, an indicator of neutro-
phil infiltration, in the renal tissues according to the
instruction. MPO activity was defined as the quantity of
enzyme degrading 1 μmol of peroxide per minute at 37°C
and was expressed in unit per milligram protein.
Enzyme-linked immunosorbent assay (ELISA)
The supernatant from kidney homogenate was prepared
for detecting the levels of TNF-α, IL-1β, and IL-6 with a
commercial available ELISA kit following the instruc-
tions of the manufacturer (Uscn Life Science Inc,
Wuhan, China). The absorbance was read on a micro-
plate reader and the concentrations were calculated ac-
cording to the standard curve. Protein content in thesample was determined by Coomassie blue assay and the
results were corrected per microgram of protein.
Statistical analysis
Data were analyzed using Prism 4 (GraphPad Software,
San Diego, CA, USA) and expressed as mean ± standard
deviation. Multiple groups were compared using one-
way analysis of variance followed by the Tukey-Kramer
test for post-hoc comparisons. Statistical significance
was set at P < 0.05.
Results
ATX protects HETCs against H2O2-induced death
As shown in Figure 1, H2O2 decreased the cell viability in
a dose dependent manner. The concentration of 100 μM
was further used for the determination of H2O2-inudced
cell damage in the present experiments. ATX at different
concentration (250, 500, 1000, 2000 nM) did not show
toxic effect on the cells (Figure 1B). The concentration of
250 nM was used for the further experiment. As shown in
Figure 1C, ATX significantly increased the viability of
HTECs exposed to H2O2.
ATX preserves renal function and renal histology
Two time points (12 h after and 24 h after IR procedure)
were chosen to evaluate serial changes in serum levels of
BUN and Cr. As shown in Figure 2A-B, both BUN and
Cr levels were significantly higher in IR group than sham
group and sham +ATX group. Pretreatment with ATX
showed positive effect in preserving renal function,
reflected by significantly reduced BUN and Cr levels in
IR + ATX group. There was no significance between
sham group and sham +ATX group.
To determine the effect of ATX on IR-induced renal
injury, a histological scoring system base on the typical
microscopic features of acute tubular damage including
tubular necrosis and dilatation, cast formation, and loss
of brush border was adopted (Additional file 1: Figure S2).
At 24 hours after the IR procedure, the injury score was
highest in IR group, significantly higher than sham group.
The injury score in IR +ATX group was significantly re-
duced compared with IR group, suggesting the protective
effect of ATX for IR-induced renal injury (Figure 2C-D).
ATX alleviates oxidative stress
Levels of SOD and MDA were used to evaluate oxidative
stress in kidney. As shown in Figure 3, level of SOD was
significantly higher while level of MDA was significantly
lower in IR group compared with sham group, indicating
oxidative stress in the kidney 24 h after IR procedure.
Pretreatment of ATX reversed oxidative stress in IR +
ATX group, reflected by significantly increased SOD
level and decreased level of MDA compared with IR
group.
Figure 2 ATX preserves renal function and histology after IR. (A-B) Circulating levels of urea nitrogen (BUN) and creatinine (Cr) in different
experimental groups (n = 6 in each group). (C) Representative images of HE staining of kidney sections in each experimental groups, showing
significantly higher degree of tubular damage including tubular necrosis (yellow arrow), cast formation (green asterisk), dilatation of tubules (red
asterisk), loss of brush border (yellow asterisk) in IR group. Please note that dilatation of Bowman’s capsule (red arrow), and accumulation of red
blood cells in tubules (green arrow) could also be observed in IR groups, suggesting the damage to glomerular. (D) Results of total histopathological
scores reflecting tubular damage in each group. *, P < 0.05 compared with IR group.
Figure 1 Protective effect of ATX on H2O2-induced cell death. (A) HTECs were incubated with different concentrations of H2O2 for 2 h.
(B) HTECs were incubated with different concentrations of ATX for 24 h. (C) HTECs were pretreated with ATX (250 nM) for 24 h and then exposed
to H2O2 (100 μM) for 2 h. *, P < 0.01 compared with control group, #, P < 0.01 compared with H2O2 group.
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Figure 3 ATX alleviates oxidative stress after IR. Levels of SOD (A) and MDA (B) in the renal tissue in each experimental group. *, P < 0.05
compared with IR group.
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procedure
To investigate IR associated apoptotic cells, we mea-
sured TUNEL positive cells in kidney tissues. As shown
in Figure 4, 24 hours after IR, no apoptotic cells were
observed in the kidney from sham group and sham +
ATX group. The number of apoptotic cells increased sig-
nificantly in IR group compared with sham group. In
contrast, tissues from IR + ATX group contain a signifi-
cantly smaller number of TUNEL-positive apoptotic
cells.
Effects of ATX on decreasing inflammation in kidney after IR
MPO activity in kidney tissue and the protein levels of
inflammatory cytokines including TNF-α, IL-1β, and IL-
6 were used to evaluate inflammation in kidneys after IR
procedure. As shown in Figure 5A, the MPO activity in
IR group was significantly higher than that in sham
group 24 h after IR, indicating neutrophil infiltration
after IR procedure. Compared with IR group, ATX pre-
treatment produced a significant decrease of MPO
activity.
ELISA detection showed significantly increased ex-
pressions of TNF-α, IL-1β, and IL-6 in IR group com-
pared with that in sham group, suggesting inflammation
in kidney 24 h after IR procedure. In the IR + ATX
group, the levels of inflammatory cytokines decreased
significantly compared with the IR group (Figure 5B).
ATX reduces the expression of α-SMA in tubular cells
after IR
α-SMA positive myofibroblasts are the main actors in
the pathogenesis of renal fibrosis. Because α-SMA pro-
duction is modulated by ROS in some cell lines, we in-
vestigated the expression of this myofibroblast marker in
our mice model of IR injury. As shown in Figure 6, al-
most none α-SMA expression could be detected withinthe interstitial space in the sham and sham+ATX group,
while a significant increase in the expression of α-SMA
was observed within the tubular areas of renal tissues 24 h
post IR procedure. In contrast, the expression of this
marker was significantly decreased in the IR +ATX group.
Discussion
This study examined the effect of ATX pretreatment on
IR-induced renal injury. Tissue distribution of ATX was
studied previously in rodent after multiple-dosage regi-
mens. The results revealed high accumulation of ATX in
kidneys [24]. In the present study, ATX was dissolved in
olive oil and administrated at a dosage of 5 mg/kg/day
via oral gavage for 14 consecutive days before the induc-
tion of renal IR. The dosage of 5 mg/kg/day was selected
based on our preliminary results that dosage of 10 mg/
kg/day or 20 mg/kg/day did not show significantly en-
hanced efficacy in ameliorating renal function (Additional
file 1: Figure S2).
ATX pretreatment leaded to an impressive protection
in IR induced renal injury reflected by significantly in-
creased viability of HTECs (Figure 1) and lower total
histopathological score (Figure 2). As stated previously,
the total histopathological score was obtained by sum-
mation of all scores given to tubular necrosis, cast for-
mation, tubular dilation, and loss of brush border [22].
The histopathological evaluation revealed that total in-
jury score was significantly ameliorated in ATX pre-
treated kidneys underwent IR as compared to non
pretreated control. BUN and Cr, which are clinically
used as markers to reflect renal function, were used in
the present study to reflect renal function post IR. Al-
though the functional differences between ATX pre-
treated group and non-treated control is significant
(Figure 1), the decline of BUN or Cr in ATX pretreated
groups was not consistent with that of histopathological
score in ATX pretreated group. This might be because
Figure 5 Effects of ATX on decreasing inflammation in kidney after IR. (A) Results of MPO activity in renal tissue in each experimental
group. (B-D) Levels of TNF-α, IL-1β, and IL6 in renal tissues in each group. *, P < 0.05 compared with IR group.
Figure 4 ATX reduces tubular apoptosis after IR. (A) Representative images of TUNEL staining of kidney sections in each experimental groups.
(B-C) High magnification of the boxed area. White arrows show TUNEL positive cells. (D) Results of the number of apoptotic cells in kidney
sections in each group. *, P < 0.05 compared with IR group.
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Figure 6 Effects of ATX on reduces the expression of α-SMA in tubular cells after IR. (A-D) Representative images of immunofluorescent
staining of α-SMA of kidney sections in each group. (E) High magnification of the boxed area in C further shows the α-SMA expression in renal
tissues. (F) Results of the expression of α-SMA in renal sections in each group. *P < 0.05 compared with IR group.
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function of glomerular. Therefore, it gives us inspiration
that more sensitive markers might be needed to fully re-
flect the renal injury after IR.
As well demonstrated, the similar molecular structure
to β-carotenoid gives ATX the capacity to scavenge free
radicals and protect oxidative damage to cell mem-
branes, cells, and tissues [15]. ASX can stabilize free rad-
icals by adding them to its long double-bond chain
rather than donating an atom or electron to the radical[25]. In the present study, SOD and MDA, which are
commonly used as biomarkers to reflect oxidative stress,
were used to evaluate oxidative stress in kidney post IR.
Significantly reduced levels of SOD and MDA in the
ATX pretreated kidney compared with non-treated con-
trols indicated the powerful free radical scavenging ac-
tivity of ATX after IR injury (Figure 2), which was
consistent with previous studies [17,18,20]. Combined
with the preserved renal function and renal microstrucu-
tre, it’s reasonable to speculate that ATX, a powerful
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cing oxidative stress after IR. More importantly, the spe-
cific structure of ATX provides greater antioxidant
properties than other antioxidants [26]. ATX contains
two additional oxygenated groups on each ring struc-
ture, makes ATX highly polar. The polar end groups
overlap the polar edges of the all membrane, while the
non-polar middle fits the membrane’s non-polar interior.
This allows ATX to neutralize free radical or other oxi-
dant activity in both the non-polar center of the mem-
brane, as well as along the polar boundary zones of the
membrane (Additional file 1: Figure S1) [26,27]. Further-
more, since ATX stabilizes free radicals by adding them
to its long double-bond chain rather than donating an
atom or electron to the radical, it can resist chain reac-
tions that occur when a fatty acid is oxidized, thus allow-
ing it to scavenge or quench longer than antioxidants
that cannot stop the chain reaction [25].
As stated in introduction, oxidative stress, a major
contributor to the pathogenesis of IR, leads to tubular
apoptosis/necrosis and triggers local inflammatory re-
sponse in IR injury [7]. In the present study, tubular
apoptosis, necrosis (Figure 1 and Figure 3) and inflam-
mation (Figure 4) were shown to be prominent features
24 h post IR. Pretreatment of ATX significantly reduced
tubular apoptosis/necrosis and inflammation after IR in-
jury. Considering the crucial role of oxidative stress in
inducing pathological changes of IR and the antioxidant
properties of ATX, ATX might alleviate tubular necrosis/
apoptosis and inflammation via scavenging free radicals.
Oxidative stress and inflammation caused by IR could
induce EMT [9,28]. Although the role of EMT in the
pathogenesis of end-stage renal fibrosis is debated, α-
SMA expression by tubular cells has been suggested to
be an early marker of progressive graft damage in kidney
transplantation [29]. α-SMA is a specific marker for
myofibroblasts, the main cellular type involved in tissue
fibrosis [30]. In the present study, significantly increased
α-SMA expression was detected in the tubular cells 24 h
after IR injury, which is consistent with previous study
using a swine model [31]. The over-expression of α-
SMA in tubular cells could partially reflect tubular injury
by oxidative stress and inflammation. There is an in-
creasing body of evidence suggesting that IR injury not
only causes acute tubular injury but also might be re-
sponsible for progressive renal damage leading to worse
long-term function [32]. In the present study, pretreat-
ment of ATX, in addition to reducing tubular apoptosis
and inflammation, had protective effects in decreasing
the expression of α-SMA (Figure 5). It might mainly due
to the free radical scavenging activity of ATX, and subse-
quent decreased inflammation. Although the protective
effects of ATX on long-term renal fibrosis was not deter-
mined in the present study, ATX might have positiveeffect in protecting kidney from fibrosis via regulating
EMT early after IR injury.
Conclusion
In conclusion, our data showed that pretreatment of ATX
was effective in protecting IR-induced acute injury includ-
ing tubular apoptosis/necrosis, inflammation, and EMT
via scavenging free radicals (Additional file 1: Figure S4).
Since ATX has been approved by the US FDA in 1999 as a
dietary supplement [13], it might be a safe and effective
strategy for kidney transplantation in preventing acute in-
jury caused by IR.
Additional file
Additional file 1: Supplementary materials.
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